PHEBENA RENCY: Open Payments
NPI 1780386441 · YARDLEY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 20 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $200 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $113 |
| Lilly USA, LLC | 2 | $45 |
| PFIZER INC. | 2 | $36 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Amgen Inc. | 1 | $26 |
| Axsome Therapeutics, Inc. | 1 | $22 |
| ABBVIE INC. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
Products named: MOUNJARO, Wegovy, SPRAVATO, AIRSUPRA, REPATHA, Auvelity, PAXLOVID, VRAYLAR.
Industry payments across PA — which companies pay providers there.
